Late infections are arbitrarily defined as those occurring later than three months after transplant. Most of these infections are bacterial,' with an unexpectedly high incidence of serious or fatal pneumococcal disease2; they occur more often in bone marrow transplant recipients with active chronic graft versus host disease.3 Chronic graft versus host disease occurs in about 30% of long term survivors of bone marrow transplantation4 and is related to a wide range of cellular and humoral immunological abnormalities.5-This immune imbalance predisposes patients to infection, contributing to morbidity and mortality in the late post-transplant period.
HLA non-identical transplants are associated with an increased risk of late infections,' and the use of the selective immunosuppressant cyclosporin A can be expected to increase the number of such transplants performed.
There is an obvious place for any laboratory test which could be used in the diagnosis and 
